Lemonaid Health Now Offers Prescription ED Medication STENDRA Through Collaboration with Petros Pharmaceuticals
| PTPI Stock | USD 0.1 0 2.00% |
Under 65% of Petros Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Petros Pharmaceuticals suggests that many traders are alarmed. Petros Pharmaceuticals' investing sentiment shows overall attitude of investors towards Petros Pharmaceuticals.
Petros |
Lemonaid Health will offer customers more affordable access to fast-acting branded ED medication that works as quickly as 15 minutes prior to sexual activitySUNNYVALE, Calif., May 14, 2024 -- Lemonaid Health, Inc., a subsidiary of 23andMe Holding Co., , and a leading telemedicine provider, is now offering Petros Pharmaceuticals, Inc.s , prescription erectile dysfunction medication STENDRA through its telehealth platform. Working direct
Read at finance.yahoo.com
 |
Petros Pharmaceuticals Fundamental Analysis
We analyze Petros Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Petros Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Petros Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Petros Pharmaceuticals is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Petros Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Petros Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Petros Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Petros Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Petros Pharmaceuticals Related Equities
| SNOA | Sonoma Pharmaceuticals | 3.18 | ||||
| SHPH | Shuttle Pharmaceuticals | 1.67 | ||||
| PRFX | Painreform | 1.61 | ||||
| SBFM | Sunshine Biopharma | 1.33 | ||||
| LFCR | Lifecore Biomedical | 1.21 | ||||
| AKAN | Akanda Corp | 1.20 | ||||
| SXTC | China SXT | 0.22 | ||||
| TKNO | Alpha Teknova | 1.37 | ||||
| CPIX | Cumberland Pharmaceuticals | 2.21 | ||||
| EVOK | Evoke Pharma | 4.51 | ||||
| CPHI | China Pharma | 19.23 |
Complementary Tools for Petros Stock analysis
When running Petros Pharmaceuticals' price analysis, check to measure Petros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Petros Pharmaceuticals is operating at the current time. Most of Petros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Petros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Petros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Petros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |